Indian Pharma Q2 Preview: Steady Growth Amid Challenges
India's pharmaceutical sector gears up for Q2 FY25 with projected 5-7% revenue growth, navigating US pricing pressures and domestic GST reductions while maintaining stable profitability.
India's pharmaceutical sector gears up for Q2 FY25 with projected 5-7% revenue growth, navigating US pricing pressures and domestic GST reductions while maintaining stable profitability.
Corporate India's Q2 performance falls short of expectations, but analysts remain bullish on second-half FY25 recovery. Discover what's driving the optimism despite current challenges.
India's automobile export sector shows robust growth with 26.3% increase in Q2 FY25. Passenger vehicles and two-wheelers lead the charge, signaling strong global demand for Indian-made vehicles.
India's automobile export sector shows robust growth with 26% increase in Q2 FY25. Discover how passenger vehicles and two-wheelers are driving this impressive expansion in global markets.
HDFC Bank reports impressive Q2 FY25 results with 10.8% net profit growth reaching ₹18,640 crore. Discover how India's leading private bank achieved robust performance despite economic headwinds.
HDFC Bank reports robust Q2 FY25 performance with 11% profit growth, 5% rise in net interest income, and significant improvement in asset quality metrics. Key highlights and analysis.
Discover the fascinating contrast between Mackenzie Scott's unprecedented philanthropic journey and the financial paths of other Bezos family members in this revealing analysis.